MBX(MBX Biosciences, Inc.) · 内部人交易

MBX(MBX Biosciences, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

MBX 最近的内部人买卖(Form 4)
交易日姓名职务类型股数价格
2026-11-10Hoerter Steven L.Chairman, President and CEO公开市场卖出4,893$54.82
2026-11-04Azoulay SalomonChief Medical Officer公开市场卖出373$53.96
2026-08-04Azoulay SalomonChief Medical Officer公开市场卖出370$65.77
2026-05-08Azoulay SalomonChief Medical Officer公开市场卖出15,003$38.30
2026-05-08Azoulay SalomonChief Medical Officer公开市场卖出55,000$38.38
2026-05-06Azoulay SalomonChief Medical Officer公开市场卖出231$29.54
2026-05-06Hawryluk P. KentPresident & CEO公开市场卖出607$29.54
2026-03-13Hawryluk P. KentPresident & CEO公开市场买入18,500$28.41
2025-10-20Hawryluk P. KentPresident & CEO公开市场买入20,000$13.64
2025-10-17Hoerter Steven L.董事公开市场买入20,000$13.25
2025-09-26Heron Patrick J董事、10% 股东公开市场买入666,666$18.00
2025-04-08Pescovitz Ora H.董事公开市场买入7,693$5.89
2025-02-18GORDON CARL L董事、10% 股东公开市场买入94,100$10.84
2025-02-18GORDON CARL L董事、10% 股东公开市场买入49,070$10.84
2025-02-18ORBIMED ADVISORS LLC董事、10% 股东公开市场买入94,100$10.84
2025-02-18ORBIMED ADVISORS LLC董事、10% 股东公开市场买入49,070$10.84
2025-02-14GORDON CARL L董事、10% 股东公开市场买入29,540$9.85
2025-02-14GORDON CARL L董事、10% 股东公开市场买入17,962$9.90
2025-02-14ORBIMED ADVISORS LLC董事、10% 股东公开市场买入29,540$9.85
2025-02-14ORBIMED ADVISORS LLC董事、10% 股东公开市场买入17,962$9.90

MBX Biosciences, Inc. MBX